Changes in the Lipidome Are Associated With Immune Activation and Subclinical Vascular Disease in Youth With Human Immunodeficiency Virus in Uganda
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae461 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Sahera Dirajlal-Fargo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Infectious Disease, Ann and Robert Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Hauptthemen laut MEDLINE: HIV Infections, Lipidomics, Vascular Diseases, Lipids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAID NIH HHS, Clinical and Translational Science Collaborative of Cleveland.
Abstract (Originalsprache)
Background
This study examined the changes in the lipidome and associations with immune activation and cardiovascular disease (CVD) markers in youth with perinatally acquired human immunodeficiency virus (YPHIV).
Methods
The serum lipidome was measured in antiretroviral therapy (ART)–treated YPHIV (n = 100) and human immunodeficiency virus–uninfected children (n = 98) in Uganda. Plasma markers of systemic inflammation, monocyte activation, gut integrity, and T-cell activation, as well as common carotid artery intima media thickness and pulse wave velocity (PWV), were evaluated at baseline and 96 weeks.
Results
Overall, median age was 12 years, and 52% were females. Total cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein were similar between the groups; however, the concentrations of ceramides, diacylglycerols, free fatty acids, lysophosphatidylcholines, and phosphatidylcholines were higher in YPHIV (P ≤ .03). Increases in phosphatidylethanolamine (16:0 and 18:0) correlated with increases in soluble CD163, oxidized LDL, C-reactive protein, intestinal fatty acid binding protein, and PWV in YPHIV (r ≥ 0.3).
Conclusions
YPHIV successfully suppressed on ART have elevated lipid species that are associated with CVD, specifically palmitic acid (C16:0) and stearic acid (C18:0).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Infectious Disease, Ann and Robert Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
- School of Health and Rehabilitation Sciences, Ohio State University, Columbus.
- Department of Pediatrics, Makerere University.
- Joint Clinical Research Center, Kampala, Uganda.
- Case Western Reserve University School of Medicine, Cleveland, Ohio.
ORCID-Profile: Sahera Dirajlal-Fargo
Förderung
- NCATS NIH HHS
- NIAID NIH HHS
- Clinical and Translational Science Collaborative of Cleveland
- NIH Roadmap for Medical Research
- (NIH)
- NICHD NIH HHS
- National Institute of Allergy and Infectious Diseases
- University Hospitals Cleveland Medical Center Clinical Research Center
Zitieren
APA
Dirajlal-Fargo, S., Nikahd, M., Ailstock, K., Manubolu, M., Musiime, V., Kityo, C., McComsey, G. A., & Funderburg, N. T. (2025). Changes in the Lipidome Are Associated With Immune Activation and Subclinical Vascular Disease in Youth With Human Immunodeficiency Virus in Uganda. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae461
Vancouver
Dirajlal-Fargo S, Nikahd M, Ailstock K, Manubolu M, Musiime V, Kityo C, et al. Changes in the Lipidome Are Associated With Immune Activation and Subclinical Vascular Disease in Youth With Human Immunodeficiency Virus in Uganda. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae461
BibTeX
@article{DirajlalFargo2025,
author = {Dirajlal-Fargo, Sahera and Nikahd, Melica and Ailstock, Kate and Manubolu, Manjunath and Musiime, Victor and Kityo, Cissy and McComsey, Grace A and Funderburg, Nicholas T},
title = {Changes in the Lipidome Are Associated With Immune Activation and Subclinical Vascular Disease in Youth With Human Immunodeficiency Virus in Uganda},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae461}
}
EUVIMED